Natural Beauty Bio-Technology Limited

Sümbol: 0157.HK

HKSE

0.51

HKD

Turuhind täna

-67.5714
P/E suhe
-2.4025
PEG suhe
1.02B
MRK Cap
0.00%
DIV tootlus

Natural Beauty Bio-Technology Limited (0157-HK) Finantsaruanded

Q: Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on .

Download

Aastane Quarterly

Lineaarne Log

Diagrammil näete Natural Beauty Bio-Technology Limited (0157.HK) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Aastane Quarterly

10Y 20Y 30Y 40Y

Bilanss

Sukeldudes Natural Beauty Bio-Technology Limited fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002
balance-sheet.row.cash-and-short-term-investments	166.8	168.6	197.1	165.6	149.1	183.9	288.9	428.6	502.7	583.3	507.4	432.4	558.7	575.5	559.3	546.2	588.7	356.2	338.7	235.9	170.3	304.9	141.9
balance-sheet.row.short-term-investments	8.1	8	8.9	7.5	10.1	2.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	88.1	65.8
balance-sheet.row.net-receivables	85.4	80.9	119.9	118.9	103.7	71.3	98.2	73	41.2	50.8	83.7	55.1	0	44.7	0	93	0	164.9	141.2	124.6	130.7	0	0
balance-sheet.row.inventory	77.6	98.8	121	103.3	85.5	74.3	85.1	49.8	46.9	45	47	67.4	40.3	46.7	89.1	100.9	71	63.6	56.5	55.7	62.7	52.7	52.7
balance-sheet.row.other-current-assets	13.3	16.3	12.1	12	21.2	18.2	19.7	14.5	18.8	17	29.3	0.3	56.2	0.4	86.1	0.4	99.2	28	26.7	94.4	67.6	101.1	64.4
balance-sheet.row.total-current-assets	343	364.6	450	399.8	359.5	347.8	491.9	565.9	609.6	696.1	667.4	555.2	655.2	667.3	734.5	740.5	759	612.7	563.2	510.6	431.3	458.8	258.9
balance-sheet.row.property-plant-equipment-net	270.6	238.4	417.1	369.6	345	197.2	198.6	173.5	187.4	223.7	257.2	285.1	261.1	232.1	217.8	230.6	218	335.7	338.4	353.4	352.5	362.2	377.7
balance-sheet.row.goodwill	25.2	25.7	29.6	28.8	27.4	31.4	27.1	25.5	27	28.3	28.4	27.6	27.5	26.6	25.8	25.8	24.6	23.2	13.9	16.8	23.6	0	0
balance-sheet.row.intangible-assets	0	25.7	35.3	42.9	42.4	17.1	27.1	25.5	27	9.1	9.5	9.5	0	0	0	0	0	0	0.9	2.1	3.2	16.5	5.5
balance-sheet.row.goodwill-and-intangible-assets	25.2	51.4	64.9	71.7	69.8	48.5	27.1	25.5	27	28.3	28.4	37.1	27.5	26.6	25.8	25.8	24.6	23.2	14.8	18.9	26.8	16.5	5.5
balance-sheet.row.long-term-investments	217.7	228.7	9.5	8.8	7.9	11.2	7.9	8.9	10.2	250	284.6	-6.3	0	0	0	0	0	7.2	7.3	7.4	12.2	-76.9	-61.3
balance-sheet.row.tax-assets	24.4	25.2	25	19	12.9	5.2	217.8	190.2	0.6	2	1	0.7	0	0	3	9.2	7.5	9.4	4.7	4.7	9.8	0.8	1
balance-sheet.row.other-non-current-assets	1.6	-24.7	-29.3	-28.1	-27	-16.4	-225.7	-199.1	-10.8	-252	-285.6	12.3	14.8	14.9	18.2	20.2	23.2	9.5	9	5.2	8.7	100.1	65.8
balance-sheet.row.total-non-current-assets	539.5	518.9	487.1	441	408.6	245.7	225.7	199.1	214.4	252	285.6	328.8	303.4	273.6	264.8	285.7	273.3	385	374.3	389.6	410.1	402.7	388.6
balance-sheet.row.other-assets	0	0	0	0	0	85.4	60.3	57.2	64.6	29.7	29.1	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	882.6	883.5	937.2	840.8	768.1	679	777.9	822.2	888.6	977.7	982.1	884.1	958.6	940.9	999.3	1026.2	1032.3	997.7	937.5	900.2	841.4	861.5	647.5
balance-sheet.row.account-payables	20.7	9.8	15.2	26.1	26.2	20.5	21.5	20.9	14.9	18.6	21.3	18	135.8	126.1	93.8	106	90.3	70.2	82	55.5	53.7	82.8	135.2
balance-sheet.row.short-term-debt	171.7	119.4	94.8	59.5	22.1	-22.6	-6	-6.2	-6.6	0	0	0	0	0	0	0	0	0	0	0	0	0	2.1
balance-sheet.row.tax-payables	3	7.5	19.3	9.7	4.7	9.7	18.4	24.3	28	43.8	26.7	12.7	12.8	9	14.5	41.2	4.7	27.6	15.8	20.7	13.5	11.3	20.8
balance-sheet.row.long-term-debt-total	3.5	6	9.5	2.3	10.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Revenue Non Current	0	24.1	24.8	13.3	20.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	71.2	104.8	114.4	107.2	82.5	105.3	94.1	141.8	128.7	172.6	159.6	108	19.3	19.6	24.8	51.6	14.5	37	24.2	29.9	18.8	16.6	20.8
balance-sheet.row.total-non-current-liabilities	24.7	35.3	41.3	24.9	42.1	1.3	11.5	4.8	12.3	12.6	13	10.1	15.3	12.6	11.9	12.3	11.9	11.3	10.9	10.2	8.4	7.6	6.8
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	11.1	18	24.8	13.3	20.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	308.1	286.1	279.2	229.5	200.3	127.1	127.1	167.5	156	203.8	193.8	136.1	170.4	158.3	130.5	169.8	116.7	118.5	117.2	95.6	80.8	107	164.9
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.1	200	0	0	0	0	0	0
balance-sheet.row.retained-earnings	39.1	54.6	85.4	50.3	42.8	189.1	259	314	355.5	361.3	365	169.8	0	0	0	0	0	0	0	0	0	118.2	105.6
balance-sheet.row.accumulated-other-comprehensive-income-loss	263.6	271.1	294.7	277.1	241.3	255.1	284.9	220.4	256.8	128.8	139.5	-129	-104.1	-96.2	-117.3	-118.7	-141.8	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	71.6	71.6	77.6	83.6	83.6	-92.6	-93.3	-79.9	-79.9	83.6	83.6	507.1	691.9	678.4	785.2	768.6	851.4	878.7	813.5	795	750.4	615.9	348.7
balance-sheet.row.total-stockholders-equity	574.5	597.5	657.9	611.2	567.8	551.9	650.7	654.7	732.6	773.9	788.3	748.2	788	782.5	868.1	850	909.6	878.7	813.5	795	750.4	734.1	454.3
balance-sheet.row.total-liabilities-and-stockholders-equity	882.6	883.5	937.2	840.8	768.1	679	777.9	822.2	888.6	977.7	982.1	884.1	958.6	940.9	999.3	1026.2	1032.3	997.7	937.5	900.2	841.4	861.5	647.5
balance-sheet.row.minority-interest	0	0	0	0	0	0	0	0	0	0	0	-0.2	0.2	0.1	0.7	6.4	6	0.4	6.8	9.7	10.2	20.3	28.3
balance-sheet.row.total-equity	574.5	597.5	657.9	611.2	567.8	551.9	650.7	654.7	732.6	773.9	788.3	748	788.2	782.6	868.8	856.4	915.7	879.2	820.3	804.6	760.6	754.5	482.6
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	225.8	236.7	18.4	16.3	18.1	2.9	7.9	8.9	10.2	250	284.6	-6.3	0	0	3.9	5.9	9.1	7.2	7.3	7.4	12.2	11.3	4.4
balance-sheet.row.total-debt	186.3	143.5	129.1	75	52.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.1
balance-sheet.row.net-debt	27.5	-17.1	-59.1	-83.1	-86.1	-181	-288.9	-428.6	-502.7	-583.3	-507.4	-432.4	-558.7	-575.5	-559.3	-546.2	-588.7	-356.2	-338.7	-235.9	-170.3	-216.8	-74

Rahavoogude aruanne

Natural Beauty Bio-Technology Limited finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002
cash-flows.row.net-income	-15.1	-30.5	35.3	7.8	21.9	26.3	105.4	148.4	136.8	71.5	58.3	155.3	173.6	75.8	186.8	308.5	208	122.8	81	62.7	54.1	66.5	71
cash-flows.row.depreciation-and-amortization	26.6	34.3	35	37.3	30.9	24.4	20.6	22.4	33.8	38.5	39.2	33.5	23.2	19.5	21.6	17.1	17.5	21.8	25.6	7.8	0	0	0
cash-flows.row.deferred-income-tax	0	0	0	0	0	0	0	0	-12.2	-29.6	43.1	-38.6	-44.4	0	-61.1	-35.3	-50.8	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	0	0	0	0	0	0	0	0	9.3	1.1	1	-28	30.2	0	0.5	0.2	0.1	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	4.4	-0.1	-35.8	-28.1	-45	19.7	-65.7	-33.1	2.8	28.5	-44.1	-55.6	-3.5	86.4	-6.5	-14.9	110.1	-42.6	-45.9	18.5	-62.3	0	0
cash-flows.row.account-receivables	1	19.7	6.7	0.3	-42.7	25	-28.4	-29.9	9.1	31.7	-58	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	16.5	-1	-27	-24.7	-17.7	-5.3	-37.3	-3.3	-6.3	-3.3	13.9	-35.9	3.7	14.9	-3.2	-27	-7.4	-8.4	-9.2	7	-22.2	0	0
cash-flows.row.account-payables	-16.1	-23.3	-16.6	12.7	10.4	-11.7	-40.9	14.7	-35.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	3	4.4	1	-16.5	5	11.7	40.9	-14.7	35.8	0	0	-19.7	-7.2	71.5	-3.4	12.1	117.6	-34.1	-36.6	11.5	-40.1	0	0
cash-flows.row.other-non-cash-items	0.3	4.6	8.4	13.2	12.5	3.6	-39.1	-9.8	-42.7	25.5	53.9	-7	-8.7	-7.9	12.9	-6.3	-10.7	4.1	50.9	43.8	18.2	-17.8	40.2
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-69.1	-44.3	-38.1	-73.9	-76.4	-51.8	-32.3	-19	-14.4	-18.5	-22.6	-61.2	-50.7	-37.2	-17.1	-35.4	-53.8	-11.3	-24.9	-14.2	-11.8	-45.6	-74.4
cash-flows.row.acquisitions-net	0	0.3	8.2	20.1	0	-18.9	0	0	0	0	0	0	0	0	0	-3.5	1	0	0	0	-7.2	-0.9	-0.8
cash-flows.row.purchases-of-investments	0	0	-1.3	-25	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.sales-maturities-of-investments	0	0	-9	3.2	12.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-investing-activites	0	0	9	25	0	9.6	0.3	30.8	-31.7	13.8	9.4	10.6	10.2	9.5	12.9	36.5	165.2	-10.5	74.7	-8.9	14.9	-19.6	-11.9
cash-flows.row.net-cash-used-for-investing-activites	-69.1	-44	-31.2	-50.6	-63.7	-61.1	-32	11.7	-46.1	-4.7	-13.1	-50.6	-40.5	-27.7	-4.2	-2.4	112.4	-21.8	49.8	-23.1	-4	-66.2	-87.1
cash-flows.row.debt-repayment	-54.3	-31.2	-27.2	-38.8	-24.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-2.1	-0.2
cash-flows.row.common-stock-issued	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	0	-6	-6	0	0	-96.1	-99.7	-140.5	-142.3	-74.7	-25.6	-140.2	-160.2	-150.2	-137.1	-300	-185	-80.3	-61.3	-45	-52.3	-94.2	-39.8
cash-flows.row.other-financing-activites	104	55.3	47.6	68.6	45.1	0	-60.9	-50.1	0	0	0	-0.8	0	0	0	0.4	5.1	0	0	0	0	254	9.5
cash-flows.row.net-cash-used-provided-by-financing-activities	49.6	18.1	14.3	29.9	20.2	-96.1	-160.6	-190.6	-142.3	-74.7	-25.6	-140.9	-160.2	-150.2	-137.1	-299.7	-179.9	-80.3	-61.3	-45	-52.3	157.7	-30.5
cash-flows.row.effect-of-forex-changes-on-cash	1.4	-9.9	4.1	9.7	-3	-18	31.7	-23.2	-32.3	-9.9	5.4	6.2	13.1	20.1	0.3	-9.8	25.7	13.4	2.7	0.9	-0.3	0.5	-8.1
cash-flows.row.net-change-in-cash	-1.8	-27.6	30.1	19.2	-45.5	-130.7	-139.7	-74.1	-80.6	75.9	75	-125.9	-17.2	16.1	13.1	-42.5	232.5	17.5	102.8	65.7	-46.5	140.7	-14.5
cash-flows.row.cash-at-end-of-period	158.7	160.6	188.2	158.2	139	158.2	288.9	428.6	502.7	583.3	507.4	432.4	558.3	575.5	559.3	546.2	588.7	356.2	338.7	235.9	170.3	216.8	76.1
cash-flows.row.cash-at-beginning-of-period	160.6	188.2	158.2	139	184.5	288.9	428.6	502.7	583.3	507.4	432.4	558.3	575.5	559.3	546.2	588.7	356.2	338.7	235.9	170.3	216.8	76.1	90.6
cash-flows.row.operating-cash-flow	16.2	8.3	42.8	30.1	20.3	74	21.2	128	140.1	165.1	108.3	59.5	170.4	173.9	154.1	269.3	274.2	106.2	111.7	132.8	10.1	48.7	111.3
cash-flows.row.capital-expenditure	-69.1	-44.3	-38.1	-73.9	-76.4	-51.8	-32.3	-19	-14.4	-18.5	-22.6	-61.2	-50.7	-37.2	-17.1	-35.4	-53.8	-11.3	-24.9	-14.2	-11.8	-45.6	-74.4
cash-flows.row.free-cash-flow	-52.9	-36	4.7	-43.8	-56.1	22.2	-11.1	108.9	125.7	146.6	85.7	-1.7	119.6	136.7	137	233.9	220.4	94.9	86.8	118.6	-1.7	3	36.8

Kasumiaruande rida

Natural Beauty Bio-Technology Limited tulud muutusid võrreldes eelmise perioodiga NaN%. 0157.HK brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002
income-statement-row.row.total-revenue	336	335.9	487.8	410.7	438.4	369.5	399.6	475.2	506.9	505.8	439.4	483.4	591.3	485.4	538.1	592.7	450.1	363.7	357.9	358.1	320.1	306.3	254.6
income-statement-row.row.cost-of-revenue	157.3	170.6	206	193.4	190.1	146.7	94.5	122.4	109.4	117	106.3	103.6	122.2	130	122.9	86.1	77.6	68.7	73.3	82.3	61.2	86.8	63.8
income-statement-row.row.gross-profit	178.7	165.3	281.8	217.2	248.3	222.9	305.1	352.9	397.5	388.8	333.1	379.8	469.1	355.4	415.2	506.6	372.6	295	284.6	275.9	258.9	219.5	190.7
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	5.8	7	4.5	3.5	-0.4	-1	-6.1	-2.4	8.5	-26.3	0.2	-4.6	-10.2	7.7	1.4	-42.2	-28.2	108.3	145.9	112.6	125.3	103.6	76.2
income-statement-row.row.operating-expenses	182.5	188.7	237	212.9	209.2	186.7	162.7	162.8	238.8	286	259.4	227.7	295.5	279.5	230.8	198.1	164.3	167.7	207.8	176.5	194.9	162.8	117.2
income-statement-row.row.cost-and-expenses	339.8	359.3	443.1	406.4	399.3	333.4	257.2	285.2	348.2	403	365.7	331.3	417.6	409.5	353.7	284.2	241.8	236.4	281.1	258.7	256.1	249.6	181
income-statement-row.row.interest-income	1.5	1.7	2.1	1.7	1.6	3	4.3	6.2	11.7	13.5	9.3	7	0	0	2.4	0	0	0	0	0	0	0	0
income-statement-row.row.interest-expense	8.1	6.2	4.9	2.7	1.3	0	0	0	0	0	0	-3.3	0	-0.6	-8.1	0.1	0.4	-47.1	-43.1	0.3	-0.7	-3.3	-3.6
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-8.1	-0.1	3.7	4.7	-2.1	1.8	9	33.3	19.7	-10.2	19.9	0	0	0	0	0	-0.3	47.1	43.1	-0.3	0	2	2.3
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	5.8	7	4.5	3.5	-0.4	-1	-6.1	-2.4	8.5	-26.3	0.2	-4.6	-10.2	7.7	1.4	-42.2	-28.2	108.3	145.9	112.6	125.3	103.6	76.2
income-statement-row.row.total-operating-expenses	-8.1	-0.1	3.7	4.7	-2.1	1.8	9	33.3	19.7	-10.2	19.9	0	0	0	0	0	-0.3	47.1	43.1	-0.3	0	2	2.3
income-statement-row.row.interest-expense	8.1	6.2	4.9	2.7	1.3	0	0	0	0	0	0	-3.3	0	-0.6	-8.1	0.1	0.4	-47.1	-43.1	0.3	-0.7	-3.3	-3.6
income-statement-row.row.depreciation-and-amortization	26.6	34.3	35	37.3	30.9	24.4	20.6	22.4	33.8	38.5	39.2	33.5	23.2	19.5	21.6	17.1	17.5	21.8	25.6	7.8	-19.5	-28.4	-6.4
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-3.8	-23.4	44.7	4.3	39.1	37.3	137.8	162.9	150.7	126.4	63.1	155.3	173.6	75.8	186.8	308.5	208.3	127.3	76.8	99.4	83.5	85.1	79.9
income-statement-row.row.income-before-tax	-11.9	-23.5	48.5	9	37	39.2	146.7	196.2	170.4	116.3	83.1	155.3	173.6	75.8	186.8	308.5	208	174.5	119.8	99.1	83.5	87	82.2
income-statement-row.row.income-tax-expense	3.2	6.9	13.2	1.2	15.1	12.9	41.4	47.8	33.6	44.8	24.6	36.1	58.5	45.1	42.8	69.9	29.2	51.6	38.8	36.3	30.1	21.9	12.5
income-statement-row.row.net-income	-15.1	-30.5	35.3	7.8	21.9	26.3	105.4	148.4	136.8	71.5	58.3	119.3	115.1	31.3	149.6	238.5	178.7	122.8	81	62.7	54.1	66.5	71